The global cell and gene therapy clinical trials market, valued at USD 10.72 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2034. This robust growth trajectory underscores the escalating demand for innovative therapeutic solutions and the increasing investment in advanced clinical research. Notably, North America and Asia Pacific are emerging as pivotal regions in this sector, each contributing uniquely to the market's evolution.
In North America, the United States stands at the forefront, commanding a substantial share of the global market. The nation's dominance is a
Synes godt om
Kommentar
Del
